CKIP-1 can regulate physiological cardiac hypertrophy through inhibition of HDAC4 phosphorylation

被引：0
|
作者：
Ling Shukuan [1 ]
Zhang Pengfei [1 ]
Li Yuheng [1 ]
Zhao Dingsheng [1 ]
Sun Weijia [1 ]
Xu Zi [1 ]
Zhong Guohui [1 ]
Li Qi [1 ]
Song Jinping [1 ]
Li Yinghui [1 ]
Li Yingxian [1 ]
机构：
[1] China Astronaut Res & Training Ctr, State Key Lab Space Med Fundamentals & Applicat, Beijing, Peoples R China
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2014年 / 64卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
GW25-e1409
引用
收藏
页码：C38 / C39
页数：2
相关论文
共 50 条
  • [21] Empagliflozin mitigates cardiac hypertrophy through cardiac RSK/ NHE-1 inhibition
    Chen, Sha
    Overberg, Kenneth
    Ghouse, Zakiya
    Hollmann, Markus W.
    Weber, Nina C.
    Coronel, Ruben
    Zuurbier, Coert J.
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 174
  • [22] Exercise improves cardiac function and glucose metabolism in mice with experimental myocardial infarction through inhibiting HDAC4 and upregulating GLUT1 expression
    Hao Jiang
    Daile Jia
    Beijian Zhang
    Wenlong Yang
    Zhen Dong
    Xiaolei Sun
    Xiaotong Cui
    Leilei Ma
    Jian Wu
    Kai Hu
    Aijun Sun
    Junbo Ge
    Basic Research in Cardiology, 2020, 115
  • [23] YY1 protects against pathologic cardiac hypertrophy through a mechanism that involves HDAC5 interaction: Evidence of CaMKII inhibition of YY1HDAC5 interaction
    Bristow, MR
    Sucharov, C
    CIRCULATION RESEARCH, 2005, 97 (02) : E8 - E8
  • [24] Protein Kinase A prevents cardiomyocyte hypertrophy through abhydrolase domain containing 5 (ABHD5)-mediated proteolysis of Histone deacetylase 4(HDAC4)
    Jebessa, Zegeye H.
    Worst, Barbara
    Katus, Hugo A.
    Backs, Johannes
    CIRCULATION RESEARCH, 2013, 113 (04)
  • [25] YY1 protects against pathologic cardiac hypertrophy through a mechanism that involves HDAC5 interaction: Evidence of CaMKII inhibition of YY1HDAC5 interaction
    Sucharov, CC
    Bristow, MR
    JOURNAL OF CARDIAC FAILURE, 2005, 11 (06) : S92 - S92
  • [26] Exercise improves cardiac function and glucose metabolism in mice with experimental myocardial infarction through inhibiting HDAC4 and upregulating GLUT1 expression
    Jiang, Hao
    Jia, Daile
    Zhang, Beijian
    Yang, Wenlong
    Dong, Zhen
    Sun, Xiaolei
    Cui, Xiaotong
    Ma, Leilei
    Wu, Jian
    Hu, Kai
    Sun, Aijun
    Ge, Junbo
    BASIC RESEARCH IN CARDIOLOGY, 2020, 115 (03)
  • [27] Inhibition of Long Noncoding RNA lncExACT1 Induces Physiological Cardiac Hypertrophy and Protects Against Pathological Hypertrophy
    Li Haobo
    Liu Xiaojun
    Xiao Chunyang
    Li Guoping
    Yeri, Ashish
    Rosenzweig, Anthony
    CIRCULATION RESEARCH, 2019, 125
  • [28] Class I HDAC inhibition prevents Ncx1 upregulation by stabilizing an HDAC5-HDAC1/Sin3a Repressor Complex during cardiac hypertrophy.
    Wang, Sabina
    Harris, Lillianne G.
    Mani, Santhosh
    Menick, Donald
    CIRCULATION RESEARCH, 2013, 113 (04)
  • [29] Icariin inhibits hypertrophy by regulation of GPER1 and CaMKII/HDAC4/ MEF2C signaling crosstalk in ovariectomized mice
    Zhao, Wenxia
    Shan, Xiaoli
    Li, Xueqin
    Lu, Shuang
    Xia, Lei
    Chen, Huihua
    Zhang, Chen
    Guo, Wei
    Xu, Ming
    Lu, Rong
    Zhao, Pei
    CHEMICO-BIOLOGICAL INTERACTIONS, 2023, 384
  • [30] PRKAR1A Deficiency Abrogates Cardiac Hypertrophy Through Inhibition of Mitochondrial Fission
    Liu, Yuening
    Xia, Peng
    Chen, Jingrui
    Bandettini, Patricia W.
    Kirschner, Lawrence S.
    Stratakis, Constantine A.
    Cheng, Zhaokang
    CIRCULATION RESEARCH, 2020, 127
12345